Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Code:
NCT05743244
Conditions
Diabetes Mellitus, Type 1
Eligibility Criteria
Sex: All
Age: 12 - 35
Healthy Volunteers: Not accepted
Interventions
Abrocitinib 200 MG Oral Tablet
Ritlecitinib
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations